Sentences with phrase «include potential effects»

Nor do these simulations yet include potential effects of changes in the solar spectrum, including the more variable UV.

In addition, we investigated the relationship between asymmetry in intra-hemispheric intrinsic connectivity and language hemispheric dominance, including a potential effect of handedness on this relationship, thanks to an FMRI acquisition during language production from which an hemispheric functional lateralization index for language (HFLI) and a type of hemispheric dominance for language, namely leftward, ambilateral, or rightward, were derived for each individual.

«NOAA is concerned about the status of bluefin tuna, including the potential effects of the Deepwater Horizon BP oil spill on the western stock of Atlantic bluefin, which spawns in the Gulf of Mexico,» said Jane Lubchenco, Ph.D., under secretary of commerce for oceans and atmosphere and NOAA administrator.

Research in primary care and the study of environmental influences on health, including the potential effects of climate change and the health co-benefits of the low carbon economy.

Scientists are investigating the long - term impacts of toxic pollutants absorbed, transported, and consumed by fish and other marine life, including the potential effects on human health.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

These short - term factors include: unclear payrolls data due to weather effects, uncertainty over the leadership of the Fed and comments of a potential 10 percent repatriation tax for U.S. firms, according to Gallo.

There's been a lot of angst in the media and advertising industries about the potential effects of ad - blocking software, which appear to be increasing in popularity, in part because Apple's new operating system includes support for such programs.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

These include the potential adverse effects on European economic activity, on the perceived health of the global banking system, and on broader financial market conditions.

1:40 p.m.: This article was updated throughout with staff reporting, including additional details about the potential effect of the new company and analysts» observations.

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

A select few, including Johnson & Johnson, FedEx, Time Warner Inc and IBM, do disclose that they strip out the potential effect of buybacks on performance metrics.

That normal includes potential long - term health effects from wildfire smoke, especially for vulnerable groups like pregnant women, infants, the elderly, and people with respiratory impairment, Henderson said.

In the years ended December 31, 2015 and 2016 our potential dilutive shares, such as stock options, RSUs, common stock subject to repurchase, and shares of convertible Series A, A-1, B, and C preferred stock were not included in the computation of diluted net loss per share as the effect of including these shares in the calculation would have been anti-dilutive.

These risks and uncertainties include: fluctuations in U.S. and international economies and currencies, our ability to preserve, grow and leverage our brands, potential negative effects of material breaches of our information technology systems if any were to occur, costs associated with, and the successful execution of, the company's initiatives and plans, the acceptance of the company's products by our customers, the impact of competition, coffee, dairy and other raw material prices and availability, the effect of legal proceedings, and other risks detailed in the company filings with the Securities and Exchange Commission, including the «Risk Factors» section of Starbucks Annual Report on Form 10 - K for the fiscal year ended September 28, 2014.

GFI aims for diversity in their hires primarily through hiring practices that are intended to help them minimize the effects of bias, such as encouraging staff to score applications anonymously, using generalized ability tests, and meeting applicants only late in the process.88 While they've hired many women, including in seven of nine director roles, they find that their team is lacking in diversity in other ways, and they've met with Encompass to discuss further steps they can take to develop their diversity strategy.89 One staff member we spoke to mentioned that they hoped GFI would be able to begin paying interns, which might help diversify their team by broadening the pool of potential interns who could afford to take a position with GFI.90, 91

While we believe that temporary factors have amplified the drop in services inflation, the ECB will likely worry about potential second - round effects of lower oil prices and currency appreciation on the price of some other (non-energy) goods and services, including on Non-Energy Industrial Goods inflation which fell sharply, from 0.7 % to 0.3 % in February.

Clinical studies on a handful of herbs are underway, but to help you understand the benefits and risks, we've compiled a comprehensive guide to herbs, including potential uses, side effects, and precautions.

Most of garlic's health benefits include potential anti-cancer, immune - strengthening, metabolism - boosting and heart disease - preventing effects.

These include the clarity regarding the number of blows, the effects of subclinical impact, the influence of other noxious influences on the brain, potential underlying genetic susceptibility and specificity of such histological changes to sport.

Chemicals with estrogenic activity «have been reported to have potential adverse health effects in mammals, including humans, especially in fetal and infant states,» says Dr. George Bittner, a professor of neurobiology at the University of Texas at Austin who has served on many National Institutes of Health panels.

Feeding your infant a soy based formula has potential side effects that include constipation, nausea, gas, and bloating.

The AAP states that «although there are potential benefits from viewing some television shows, such as the promotion of positive aspects of social behavior (such as sharing, manners, and cooperation), many negative health effects also can result,» including increases in:

Fenugreek is used generously by many lactating women, professionals included, without the knowledge or awareness of it's potential side effects.

Reglan's potential side effects include depression, and domperidone is not FDA - approved in the U.S. Herbs have allergic potential and may harbor contaminants.

The overuse of social media, including Facebook, can have a definite impact on teenagers and parents should be aware of the potential negative effects on kids.

Potential side effects can include mild headaches, occasional menstrual irregularities, or mild abdominal cramping.

In consideration of potential adverse effects, we recommend pacifier use for infants up to 1 year of age, which includes the peak ages for SIDS risk and the period in which the infant's need for sucking is highest.

The potential benefits of the Unicef baby friendly initiative of accrediting health facilities are considerable and now evidence based.6 There are also indications that the initiative has led to an arrest in the worldwide decline in breast feeding.7 Training of health workers is an essential prerequisite to reducing the harmful effects of health services, but pretraining should be carried out systematically and periodically so that new workers are included, and there should be an emphasis on the development of advocacy skills.

2) Will the Commission ask EFSA to evaluate potential risks of high sugar levels in baby foods and young child formula, including effects on levels of childhood obesity and on the developing taste palates of children?

We examined the potential confounding effects of home tap water As concentration and sex, but because these factors were unrelated to urinary As concentrations, we report only the models including specific gravity.

Krueger acknowledged the potential for harm with legalization, including the effect on youth and the danger of driving while intoxicated during the panel.

Under the Kavanagh / Squadron bill, the factors applicable to all license applications would include the number, type, and proximity of other licenses in the area; whether the applicant has necessary permits; the potential effect of the license on traffic and parking; noise levels; any history of liquor violations or criminal activity at the premises; any history of building and fire violations at facilities operated or owned by the applicant; and any formal communications about the application from the municipality or community board.

The Quinnipiac poll finds that by a narrow four point margin, New Yorkers surveyed believe that the economic benefits of natural gas drilling, including job creation, outweigh the potential harmful environmental effects.

Dr. Shah has revealed that he's traveled to other states, including neighboring Pennsylvania, to learn more about the potential health effects of the gas drilling process.

While the national political establishment has fretted about the potential negative effects of a Trump nomination — including his ability to win Hispanic voters in a general election — much of Long Island's Republican establishment has embraced him.

Product stewardship includes cradle - to - grave responsibility for the potential health impact, safety, and environmental effects of a company's products.

The U.S. Food and Drug Administration originally approved the drug in 1999, but subsequent case reports of abnormal behavior in adolescents who used the medication led the agency in 2006 to require that all packaging of the drug include a warning label about potential neuropsychiatric side effects, such as hallucinations, delirium, self - harm and even suicide.

Examples of potential problem include unforeseen immune reactions or altering the wrong sequence of DNA — so - called off - target effects.

Many factors are currently considered, including a measure's expected effect on patients and health care, potential for promoting improvement, scientific underpinnings, usability, and feasibility.

We look at the contents of the July issue of Scientific American magazine, the last under outgoing Editor in - Chief John Rennie, including an article by moon explorer Harrison Schmitt, a piece on the fight against superbugs, a report on the potential of biofuels such as grassoline, and a recollection of the pernicious effects of chess!

We look at the contents of the July issue of Scientific American magazine, the last under outgoing Editor in Chief John Rennie, including an article by moon explorer Harrison Schmitt, a piece on the fight against superbugs, a report on the potential of biofuels such as grassoline, and a recollection of the pernicious effects of chess!

This association held even after the researchers accounted for other potential factors, including total population, number of law enforcement employees, median age, gender distribution, race distribution, poverty rate, unemployment rate, unobserved heterogeneity among cities (e.g., city area, legal system), and unobserved time - varying effects (e.g., macroeconomic conditions).

Potential adverse side effects include toxicity of the nervous system, kidney and liver, headaches, and rare, but serious skin conditions such as Stevens Johnson syndrome and toxic epidermal necrolysis.

Seventy per cent of the websites provided information on the safe usage of prescription medications, including potential side effects or adverse reactions when combined with other drugs.

Besides the exact chemical structures, various issues had to be explained scientifically including biodegradability (persistence), bioaccumulation, potential for long - range transport and any harmful effects of individual HBCD stereoisomers.

Chronic treatment with rapamycin has been problematic in both humans and mice; the drug has the potential to cause deleterious metabolic side effects including weight gain and glucose insensitivity.

Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse — limiting its utility as an antidepressant.

NSAID labels include warnings about potential increases in blood pressure but there is little data on the effects of individual drugs.